chr12-120999581-C-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000545.8(HNF1A):c.1722C>A(p.Ser574Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,612,424 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S574G) has been classified as Benign.
Frequency
Consequence
NM_000545.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HNF1A | NM_000545.8 | c.1722C>A | p.Ser574Arg | missense_variant | 9/10 | ENST00000257555.11 | |
HNF1A | NM_001306179.2 | c.1743C>A | p.Ser581Arg | missense_variant | 9/10 | ||
HNF1A | NM_001406915.1 | c.1530C>A | p.Ser510Arg | missense_variant | 8/9 | ||
HNF1A | XM_024449168.2 | c.1815C>A | p.Ser605Arg | missense_variant | 8/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HNF1A | ENST00000257555.11 | c.1722C>A | p.Ser574Arg | missense_variant | 9/10 | 1 | NM_000545.8 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000926 AC: 141AN: 152236Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000243 AC: 59AN: 242772Hom.: 0 AF XY: 0.000121 AC XY: 16AN XY: 132392
GnomAD4 exome AF: 0.000103 AC: 150AN: 1460070Hom.: 1 Cov.: 35 AF XY: 0.0000771 AC XY: 56AN XY: 726378
GnomAD4 genome AF: 0.000925 AC: 141AN: 152354Hom.: 1 Cov.: 33 AF XY: 0.000966 AC XY: 72AN XY: 74502
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 06, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 05, 2018 | - - |
Maturity onset diabetes mellitus in young Benign:1Other:1
Uncertain risk allele, criteria provided, single submitter | research | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs141304623 with MODY3. - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 13, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Monogenic diabetes Benign:1
Likely benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Nov 10, 2015 | ACMG Criteria: PP3, BS2 (type2diabetesgenetics.org), BP4 - |
HNF1A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 07, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at